docj, since we don't get play by play from the company, we
docj, since we don't get play by play from the company, we are limited to speculation. That is almost always the case with microcap biotech. However, we now have a CEO who has a long clinical and professional relationship with Cytodyn and Leronlimab. I choose to believe that he and the team are lining up their ducks in order to submit articles, develop protocols for studies, and arrange funding. Silence does not mean nothing is happening, but that real work is occurring behind the scene. I could be wrong, but this is the only approach that makes sense to me.
I posted the WSJ article because battling inflammation and enhancing the immune system is at the core of the LL platform. I have no expertise in these areas other than what I read here. If LL addresses multiple causes of inflammation, Ohm's list of conditions will grow exponentially. OTOH, it has to be time-consuming to sort out priorities, especially those priorities that will attract partners and/or funding.
The pps has very little relevance to LL's potential, IMO. When previous management PR'd their progress, real and aspirational, investors jumped on the train. $10 to .14 is an investing disaster. It's going to take real science and statistically significant results to regain the confidence of those investors and potential partners and get them back on the train. I'll leave it to others to explain the outside influences that may affect the share price.
16
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Paving the Way for Seamless International Shipping Supply Maverick's got a new mantra, folks: simplicity. They're slicing through the mess of international shipping and bringing some much-needed clarity for customers in Canada, Australia, and New Zealand. It’s about time someone shook up the logistics playbook. The Nuts and Bolts of the New Shipping System Imagine being...
Continue Reading
An Unstoppable Force in Fintech Well, if QuickFi hasn't made a name for itself in fintech, then folks, I don't know what to tell you. This year, they’ve snagged yet another prestigious Finovate Award—this time for Best SMB/SME Banking Solution. That's not their first rodeo either; it’s the fourth time they’ve walked away winners. It's almost like they're...
Continue Reading
Copper's New Pulse: PolarX Makes Waves in Alaska Ever hear about striking copper so rich it's practically shimmering? Well, PolarX Limited just might have hit that sweet spot up in the rugged expanses of Alaska. Let me tell you, when you're knee-deep in resources, like what they’re discovering at the Caribou Dome Project, it sure feels like you’ve struck modern-day...
Continue Reading
A Somber Day at NYSE: Reflecting on 9/11 September 11th grips the heart of NYSE every year, but this year's 25th-anniversary powerfully reverberates through its hallowed halls. The hustle of the trading floor halts for a moment at 9:20 AM ET, paying homage to those lost in the harrowing attacks. I've seen the markets flap in the wind of countless crises, but nothing's...
Continue Reading
They say good things come in bizarre packages, and that's exactly the case as David Boylan's Lick the Plate zany celebration marks 15 years on air with its 2,000th episode. If you think of radio as a predictable endeavor, well, you're not tuned into Lick the Plate. A Milepost Draped in Multicolored Fabrics When you're browsing through colorful avenues of radio fame, it's...
Continue Reading
Sustainability Investments: A Tale of Contrasts In the world of sustainability, a staggering $17 trillion has been poured into technologies over the past decade. That’s no chump change. But what do we have to show for it? According to Bain & Company’s latest report, this massive financial injection hasn’t exactly hit a home run. Progress, much like the stock market...
Continue Reading
Toss out your one-size-fits-all real estate predictions; the Q2 2026 Buy-Side Index just unveiled some real whoppers about the housing market. What we're seeing isn't your typical year-over-year growth across the board. Nope, we're seeing splits as sharp as a knife between states. Some places are shooting up in price, while others seem to be stuck in mud. Price Surges and...
Continue Reading
Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...
Continue Reading
Decoupling Oil Price and Production Response This oil market isn’t your usual rodeo. With Brent flirting with $100, it’s a seismic shift that’s not yielding new drills but redirecting capital to the existing infrastructure landscape. Ask yourself why we're not seeing the usual cavalry charge of new rigs. It’s simple: Pipeline mileage and producing wells have...
Continue Reading
A Fresh Alliance for Mental Wellness in Modeling Alright, let's shine a spotlight on a significant step in the modeling industry, a place typically less vocal about mental health. In a move that feels long overdue, Brain-Body Therapy and Mother Model Management have joined forces, marking the beginning of a collaborative effort to propel mental wellness to the forefront...
Continue Reading
Top 5 Most Recently Viewed Articles
Understanding Bitcoin's Growth Potential Bitcoin (CRYPTO: BTC) continues to capture attention as analysts highlight its potential for substantial appreciation. Former PayPal president David Marcus emphasizes that Bitcoin is "still severely undervalued" and posits that its value could rival that of gold, potentially reaching an equivalent of $1.3 million per coin. Insights...
Continue Reading
Q4 2024 Results of EQT Corporation EQT Corporation (NYSE: EQT) has recently revealed its impressive financial and operational results for the fourth quarter and full year of 2024. The earnings report shows a vigorous pace of production and optimizations that led to significant cash flow generation. Key Highlights from Q4 Some of the notable achievements for the fourth...
Continue Reading
Nature's Miracle Holding Inc. Announces $2 Million Investment Nature's Miracle Holding Inc. (OTCQB: NMHI) has successfully secured a significant investment of $2 million through the issuance of convertible preferred shares. This financial boost comes from a private investor based in Asia and marks a pivotal moment for the company as it continues to innovate in the...
Continue Reading
Sekisui Specialty Chemicals Implements Price Increase Sekisui Specialty Chemicals recently announced a significant adjustment to the pricing of its Selvol product line, including Selvol Polyvinyl Alcohol, Selvol Ultiloc, Selvol Ultalux, and Selvol Premiol products. These price adjustments will come into effect as contracts allow and are designed to adjust to market trends...
Continue Reading
Recent Activity in CRDO Options Major financial players have recently shown significant interest in Credo Technology Group, operating under the stock ticker CRDO. Our examination of the options trading history reveals intriguing insights, particularly highlighting 29 unusual trades that stand out in the current market landscape. Understanding the Sentiment Behind Trades A...
Continue Reading